FCMI
KURA icon

Foresite Capital Management IV’s Kura Oncology KURA Stock Holding History

Foresite Capital Management IV’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-816,882
Closed -$4.71M – 7
2025
Q2 		$4.71M Sell
816,882
-295,000
-27% -$1.81M 3.81% 5
2025
Q1 		$7.34M Sell
1,111,882
-615,000
-36% -$4.79M 6.61% 4
2024
Q4 		$15M Sell
1,726,882
-123,065
-7% -$1.77M 13.83% 2
2024
Q3 		$36.1M Hold
1,849,947
– – 23.62% 2
2024
Q2 		$38.1M Hold
1,849,947
– – 25.59% 2
2024
Q1 		$39.5M Hold
1,849,947
– – 19.94% 2
2023
Q4 		$26.6M Hold
1,849,947
– – 13.44% 2
2023
Q3 		$16.9M Hold
1,849,947
– – 9.37% 4
2023
Q2 		$19.6M Hold
1,849,947
– – 9.62% 5
2023
Q1 		$22.6M Hold
1,849,947
– – 11.74% 5
2022
Q4 		$23M Hold
1,849,947
– – 9.81% 5
2022
Q3 		$25.3M Hold
1,849,947
– – 8.13% 4
2022
Q2 		$33.9M Hold
1,849,947
– – 9.13% 5
2022
Q1 		$29.7M Hold
1,849,947
– – 8.32% 5
2021
Q4 		$25.9M Hold
1,849,947
– – 5.33% 7
2021
Q3 		$34.6M Hold
1,849,947
– – 5.1% 7
2021
Q2 		$38.6M Hold
1,849,947
– – 5.21% 6
2021
Q1 		$52.3M Buy
1,849,947
+41,965
+2% +$1.33M 6.26% 7
2020
Q4 		$59M Buy
1,807,982
+500,000
+38% +$17.6M 6.41% 6
2020
Q3 		$40.1M Hold
1,307,982
– – 9.04% 4
2020
Q2 		$21.3M Buy
1,307,982
+1,214,982
+1,306% +$17.5M 10.39% 3
2020
Q1 		$925K Buy
93,000
+25,000
+37% +$286K 1.14% 10
2019
Q4 		$935K Buy
+68,000
New +$1.01M 0.4% 14

Other funds holding KURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Foresite Capital Management IV's KURA Position: Q3 2025 in Review

Foresite Capital Management IV sold out of Kura Oncology (KURA) in Q3 2025, closing a stake of 816,882 shares — an estimated $4.71M sold.

Foresite Capital Management IV first reported a position in KURA in Q4 2019 and held it in 23 quarters. The position peaked at $59M in Q4 2020. 200 funds tracked by Wall St. Rank hold KURA as of Q3 2025.

  • Foresite Capital Management IV reported no remaining Kura Oncology position as of Q3 2025 after selling out during the quarter.
  • Foresite Capital Management IV sold 816,882 Kura Oncology shares in Q3 2025, an estimated $4.71M.
  • Foresite Capital Management IV first reported a position in Kura Oncology in Q4 2019 and held it in 23 quarters.
  • Foresite Capital Management IV's Kura Oncology position peaked at $59M in Q4 2020.
  • 200 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2025.

Based on Foresite Capital Management IV's 13F filing for Q3 2025, filed 14 Nov 2025.